Beyond Basic Beta Content Hub Basic Could Be Beautiful When Biotech Bounces Back By Tom LydonJune 7, 2022
ETF Building Blocks Content Hub Betting on Biotech Bear Market Expiration Date By Tom LydonMay 25, 2022
ETF Building Blocks Content Hub ALPS Launches Active Muni Bond ETF: MNBD By Elle Caruso FitzgeraldMay 20, 2022
ETF Building Blocks Content Hub Make Biotech Cash Considerations With SBIO By Tom LydonMarch 28, 2022
ETF Building Blocks Content Hub Biotech Stocks, ETFs Starting to Look Healthier By Tom LydonMarch 21, 2022
Beyond Basic Beta Content Hub Vaccine Stocks Lift Biotech ETFs as China Enters Lockdowns By Max ChenMarch 14, 2022
ETF Building Blocks Content Hub SBIO Is a Good Place to Be for Biotech Innovation By Tom LydonFebruary 28, 2022
ETF Building Blocks Content Hub Consolidation Could Come Calling for Biotech in 2022 By Tom LydonJanuary 5, 2022
ETF Building Blocks Content Hub Biotech M&A Could Finally Perk Up in 2022 By Tom LydonDecember 27, 2021
ETF Building Blocks Content Hub Memeification of Biotech Stocks Shines Light on This ETF By Tom LydonNovember 24, 2021
Innovative ETFs Content Hub Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs By Max ChenNovember 5, 2021
